The Journal of Clinical Endocrinology & Metabolism · 1989 · 159 citations · 15 references
MedicineEndocrinologyOncologyCalcium HomeostasisMetastasisMineral MetabolismParathyroid CancerParathyroid DisordersParathyroid Gland PhysiologyParathyroid NeoplasmsEctopic Hormone ProductionEctopic Parathyroid GlandsHypercalcemia Of MalignancyParathyroid Gland HistologyParathyroid Hormone BiologyParathyroid PathologySerum Calcium MeasurementTumor-induced Hypercalcemia
Severe hypercalcemia (serum calcium, 4.37-4.84 nmol/L) was found in a 70-yr-old man who had a small cell carcinoma of the lung with multiple metastases. The plasma immunoreactive PTH concentration was markedly elevated, as measured in three different PTH assays [N-terminal PTH, 4,650 ng/L (normal, 230-630); midregion PTH, 13,850 ng/L (normal, 180-560); C-terminal PTH, 9,900 ng/L (normal, less than 1,300)], but at autopsy the parathyroid glands were histologically normal. The PTH concentration of a liver metastasis was 503.5 ng/g wet wt (normal liver, less than 4.2-5.9), and the PTH in the tumor extract eluted at nearly the same position as synthetic human PTH-(1-84) on gel filtration chromatography. Northern blot analysis revealed PTH mRNA in the tumor as a single band of 0.9 kilobase. These results indicate that the ectopic PTH production by the lung cancer was the cause of hypercalcemia in this patient.
15
Biochemical Evaluation of Patients with Cancer-Associated Hypercalcemia
Andrew F. Stewart, Ronald L. Horst, Leonard J. Deftos et al. · New England Journal of Medicine · 1980 · 720 citations
Medicine, Endocrinology, Oncology +17
Marguerite Mangin, Andrew C. Webb, Barbara E. Dreyer et al. · Proceedings of the National Academy of Sciences · 1988 · 435 citations · Full text